Leukemia, Plasma Cell - 19 Studies Found

Not yet recruiting : Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma
:
  • Plasma Cell Leukemia in Remission
  • Plasma Cell Myeloma
    • : 2017-03-29
    :
    • Procedure: Autologous Hematopoietic Stem Cell Transplantation

Recruiting : SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy
:
  • Partial Response of Multiple Myeloma or Plasma Cell Leukemia
  • Pl
    : 2015-01-06
    :
    • Biological: Incomplete Freund's Adjuvant

Recruiting : Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)
:
  • Multiple Myeloma
  • Multiple Myeloma in Relapse
  • Mantle Cell L
    : 2011-09-14
    :
    • Biological: SNS01-T 0.05 mg/kg
Completed : Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
: Multiple Myeloma and Plasma Cell Neoplasm
: 2005-11-22
:
  • Dietary Supplement: ascorbic acid

Not yet recruiting : Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
:
  • Acute Myeloid Leukemia (AML)
  • Acute Lymphocytic Leukemia (ALL)
  • Drug: Fludarabine 25 mg/m^2 IV
Recruiting : Allo HSCT Using RIC for Hematological Diseases
:
  • Acute Myelogenous Leukemia
  • Acute Lymphocytic Leukemia
  • Chro
    : 2016-01-19
    :
    • Drug: Allopurinol 300 mg/day (
Recruiting : UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
:
  • Acute Leukemia
  • Acute Myeloid Leukemia
  • Acute Lymphoblastic
    : 2016-03-24
    :
    • Drug: Fludarabine Both Arms: 3
Recruiting : Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
:
  • Myelodysplastic Syndrome
  • Chronic Myelomonocytic Leukemia
  • S
    : 2015-09-21
    :
    • Drug: Fludarabine Days -6 thro
Active, not recruiting : Study of Arry-520 and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma
: Myeloma
: 2011-06-10
:
  • Drug: Arry-520 Part 1A Startin
<<< Previous